Skip to main content
. Author manuscript; available in PMC: 2016 Jan 24.
Published in final edited form as: Ann Intern Med. 2015 Jul 21;163(2):81–90. doi: 10.7326/M15-0530

Appendix Table 3.

Laboratory Results for Patient 3, the Second Domestically Acquired Ebola Virus Disease Case in the United States, October 2014

Variable Illness Day (Date in 2014)
5
(14 October)
6
(15 October)
(Transfer)
7
(16 October)
8
(17 October)
9
(18 October)
10
(19 October)
11
(20 October)
12
(21 October)
13
(22 October)
14
(23 October)
15
(24 October)
16
(25 October)
17
(26 October)
18
(27 October)
25
(3 November)
32
(10 November)
40
(18 November)
Experimental therapy BCV CVP CVP BCV - - - - - - - - - - - -
Hematology - - - - - - - - - - - - - - - -
    Leukocyte count, × 109
cells/L
2.67 (L) 3.55 (L) 6.2 4.8 6.3 6.3 5.6 6.6 6.0 6.1 5.4 (L) 5.2 5.8 6.2 5.8 4.8 6.1
    Neutrophil count, × 109
cells/L
1.95 2.22 - - - - - - - - - - - - 2.3 2.5 3.8
    Lymphocyte count, × 109
cells/L
0.62 (L) 0.97 2.72 1.79 1088
    Hemoglobin, g/dL 15.8 14.5 12.2 12.2 12.2 12.2 13.5 13.9 12.2 12.6 11.2 (L) 10.9 (L) 11.1 (L) 12.1 13.7 13.5 13.4
    Platelet count, × 109 cells/L 120 (L) 114 (L) 197 116 140 (L) 195 236 309 305 346 341 320 311 336 248 206 170
    Serum levels
    AST, U/L 255 (H) 306 (H) 195 (H) 154 (H) 241 (H) 491 (H) 393 (H) 379 (H) 293 (H) 361 (H) 318 (H) 251 (H) 183 (H) 178 (H) 42 27 24
    ALT, U/L 175 (H) 259 (H) 204 (H) 188 (H) 273 (H) 512 (H) 557 (H) 654 (H) 575 (H) 719 (H) 698 (H) 635 (H) 534 (H) 533 (H) 137 57 35
    AP, U/L 70 58 53 62 60 71 80 80 69 82 64 58 58 62 76 72 65
    Bilirubin, mg/dL 0.5 0.5 0.6 0.5 0.5 0.5 0.6 0.6 0.6 0.6 0.8 0.7 0.7 0.8 0.2 0.4 0.5
    Albumin, g/dL 3.5 2.8 (L) 3.0 (L) 3.2 (L) 3.3 (L) 3.2 (L) 3.5 3.7 3.5 3.7 3.3 (L) 3.2 (L) 3.2 (L) 3.5 3.8 3.6 3.7
    Creatinine, mg/dL 0.7 0.6 0.7 0.6 0.7 0.7 0.7 0.6 0.7 0.6 0.6 0.6 0.7 0.7 0.7 0.7 0.7
    Sodium, mmol/L 136 136 136 141 149 143 141 142 138 140 139 138 137 138 137 139 137
    Potassium, mmol/L 3.5 3.8 3.5 3.7 4.0 3.9 3.9 4.3 3.9 4.1 4.7 3.9 4.1 4.1 4.4 3.5 3.9
    Chloride, mmol/L 102 108 106 109 111 107 107 105 105 107 107 108 108 107 105 109 108
    CO2 content, mmol/L 21 19 26 27 28 28 27 28 26 25 26 27 26 28 21 21 19
    Anion gap, mmol/L 13 9 4 5 10 8 7 9 7 8 6 11 3 3 - - 10
    LDH, U/L - 751 - - - - - - - - - - - - - -
    CK, U/L - 238 - - - - - - - - - - - - - -
Maximum temperature, °C 38.9 38.9 AF AF AF AF AF AF AF AF AF AF AF AF AF AF AF
Blood EBOV qRT-PCR result Positive Positive Positive Positive - u/d u/d u/d u/d u/d u/d - - - - -
Blood EBOV qRT-PCR Ct value 30 33 37 37 - - - - - - - - - - - -
Urine EBOV qRT-PCR result - Positive Positive Positive Positive - Positive u/d u/d u/d* u/d - * - - -
Urine EBOV qRT-PCR Ct value - 34 35 39 38 - 39.5 - - - - - - - - -
EBOV IgM antibody titer u/d u/d ≥400 ≥1600 - ≥6400 ≥6400 ≥6400 ≥6400 - >1600 - - - - -
EBOV IgG antibody titer u/d u/d ≥400 ≥1600 - ≥1600 ≥1600 ≥6400 ≥6400 - >1600 - - - - -

AF = afebrile; ALT = alanine aminotransferase; AP = alkaline phosphatase; AST = aspartate aminotransferase; BCV = brincidofovir; CK = creatine kinase; Ct = cycle threshold (lower values reflect higher viral loads); CVP = convalescent plasma; EBOV = Ebola virus; H = high (above reference range); L = low (below reference range); LDH = lactate dehydrogenase; qRT-PCR = quantitative reverse transcriptase polymerase chain reaction; u/d = undetectable level (negative result). Dashes indicate no results on these days.

*

Result was also negative from skin and vaginal fluid.